Liontrust Investment Partners LLP Raises Stake in Astera Labs, Inc. $ALAB

Liontrust Investment Partners LLP raised its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 62.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 52,349 shares of the company’s stock after purchasing an additional 20,220 shares during the quarter. Liontrust Investment Partners LLP’s holdings in Astera Labs were worth $4,733,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in ALAB. Fred Alger Management LLC grew its stake in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after purchasing an additional 179,638 shares during the period. Hoey Investments Inc. boosted its holdings in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after buying an additional 1,121 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares in the last quarter. Wealth Effects LLC acquired a new position in Astera Labs during the second quarter worth about $242,000. Finally, Maryland State Retirement & Pension System increased its holdings in Astera Labs by 37.7% in the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after buying an additional 1,906 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ALAB. Raymond James Financial started coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Citigroup reaffirmed an “outperform” rating on shares of Astera Labs in a report on Tuesday, December 9th. Cowen reissued a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 17th. Finally, TD Cowen decreased their price objective on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $188.17.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 90,459 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the transaction, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 586,936 shares of company stock valued at $89,331,140. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Down 14.3%

NASDAQ ALAB opened at $148.85 on Monday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The business has a fifty day moving average of $166.62 and a 200-day moving average of $154.01. The stock has a market cap of $25.14 billion, a price-to-earnings ratio of 134.10, a price-to-earnings-growth ratio of 2.77 and a beta of 1.52.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter last year, the business posted $0.23 EPS. The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.